Cite

    Wang, L. et al. (2018). A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate–prednisone. Annals of oncology. pp. 352-360. [Online].